| Posted on: | Category: RWD/RWE
ISPOR’s Value and Outcomes Spotlight recent Sep/Oct 2020 issue contained an interesting Q&A article with Jennifer Graff (VP, Comparative-Effectiveness Research, National Pharmaceutical Council). Overall, it was interesting, ...
| Posted on: | Category: FDA
Another FDA guideline on COVID-19 has just been released and, given the pressing nature of the current pandemic, comes into immediate effect.
I’ve picked out ...
